1992
DOI: 10.1016/0008-8749(92)90002-7
|View full text |Cite
|
Sign up to set email alerts
|

Role of CR2 in the human adult and neonatal in vitro antibody response to type 4 pneumococcal polysaccharide

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
11
0

Year Published

1997
1997
2018
2018

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 32 publications
(11 citation statements)
references
References 31 publications
0
11
0
Order By: Relevance
“…It has been shown to enhance the phagocytic activity of neutrophils, stimulate monocytes, and induce autolysis in S. pneumoniae (17,32). CD21 serves as the receptor for C3d, a degradation fragment of complement component C3, and for gp350 from Epstein-Barr virus (26). Although originally described in B-lymphocytes, CD21 has also been found to be expressed in other cell types, including monocytes.…”
Section: Discussionmentioning
confidence: 99%
“…It has been shown to enhance the phagocytic activity of neutrophils, stimulate monocytes, and induce autolysis in S. pneumoniae (17,32). CD21 serves as the receptor for C3d, a degradation fragment of complement component C3, and for gp350 from Epstein-Barr virus (26). Although originally described in B-lymphocytes, CD21 has also been found to be expressed in other cell types, including monocytes.…”
Section: Discussionmentioning
confidence: 99%
“…The CR2 expression profile in equine PBMC is intriguing because it contrasts with the decreased CR2 expression reported for human neonatal B cells [123]. Low CR2 expression has been implicated as the reason why human neonatal B cells do not respond to T cell-independent antigens, such as pneumococcal polysaccharides [124]. …”
Section: Resultsmentioning
confidence: 99%
“…However, antibody responses to T-cell-dependent type II antigens remain absent or low during the first 2 years of life, which may be due to the diminished expression of CR2 or poor interaction between CR2 and secretory immunoglobulins [101,102]. The use of 8-mercaptoguanosine showed increased CR2 expression in adult and neonatal B cells, overcoming the in vitro unresponsiveness to T-cellindependent type II antigens of neonatal B cells and increasing the antibody response against type 4 p neumococcal polysaccharide (PS) antigen [101].…”
Section: Other Adjuvants N C3dmentioning
confidence: 96%